Article info
Therapeutics
Cross-over randomised controlled trial
Long-acting β-agonist step-up therapy is more likely to provide best response, compared to inhaled corticosteroid or leukotriene-receptor antagonist step-up in children with uncontrolled asthma receiving inhaled corticosteroids
- Correspondence to Mike Thomas
Cotswold Cottage, Oakridge, Stroud, Gloucs GL67NZ, UK; mikethomas{at}doctors.org.uk
Citation
Long-acting β-agonist step-up therapy is more likely to provide best response, compared to inhaled corticosteroid or leukotriene-receptor antagonist step-up in children with uncontrolled asthma receiving inhaled corticosteroids
Publication history
- First published August 16, 2010.
Online issue publication
October 25, 2017
Article Versions
- Previous version (25 October 2017).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions